Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2020 Funding Forecast
  • COVID-19

FDA Clears Nerve Stimulator to Aid Recovery from Opioids

By The Associated Press | November 16, 2017

This photo provided by Innovative Health Solutions shows the NSS-2 Bridge. On Wednesday, Nov. 15, 2017, the Food and Drug Administration announced clearance of the NSS-2 Bridge, a brain-stimulating device for patients suffering from debilitating withdrawal symptoms caused by addiction to heroin and other opioids. The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia. (Courtesy of Innovative Health Solutions, Inc. via AP)

U.S. health authorities have cleared a brain-stimulating device for patients suffering from debilitating withdrawal symptoms caused by addiction to heroin and other opioids.

The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia. The announcement Wednesday by the Food and Drug Administration comes amid an epidemic of opioid abuse, which includes both illegal narcotics like heroin and prescription painkillers.

The device, known as NSS-2 Bridge, is worn behind the ear where several electrodes stimulate nerves in the brain and spinal cord to relieve symptoms. The FDA says a study of more than 70 patients showed a 30 percent decrease in symptoms within 30 minutes of using the device.

Nerve stimulators have previously been approved to treat epilepsy and depression.

Related Articles Read More >

Berkeley Lab team introduces new approach for whole-cell visualization, using the world’s first soft X-ray tomography (SXT) microscope
R&D 100 winner of the day: Smart Microbial Cell Technology
A-LabInsider launches app to boost biotech businesses
Microbe “rewiring” technique promises a boom in biomanufacturing

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup
Tweets by @RandDWorld

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2020 Global Funding Forecast

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2020 Funding Forecast
  • COVID-19